IR News

May 12, 2021Print(PDF/105KB)Corporate

Sumitomo Dainippon Pharma Announces Changes in Board of Directors and Audit & Supervisory Board

Sumitomo Dainippon Pharma Co., Ltd. (Head Office: Osaka, Japan; Representative Director, President and CEO: Hiroshi Nomura) announced today that in its meeting held on May 12, 2021, the Board of Directors appointed the following candidates for new members of the Board of Directors as well as the Audit & Supervisory Board.

1. Change in the Members of the Board of Directors (as of June 24, 2021)

(1) New Member of the Board of Directors

Minoru Usui (currently Chairman and Director, Seiko Epson Corporation)

Note: The new member of the Board of Directors who will take office as of June 24, 2021 is subject to the approval at the general shareholders' meeting scheduled for the same date.

Minoru Usui is a candidate for Outside Director.

2. Changes in the Members of the Audit & Supervisory Board (as of June 24, 2021)

(1) New Member of the Audit & Supervisory Board

Mayumi Mochizuki (currently Professor Emeritus, Keio University)

Note: The new member of the Audit & Supervisory Board who will take office as of June 24, 2021 is subject to the approval at the general shareholders' meeting scheduled for the same date.

Mayumi Mochizuki is a candidate for Outside Audit & Supervisory Board Member.

(2) Retiring Member of the Audit & Supervisory Board

Kazuto Nishikawa (currently Outside Audit & Supervisory Board Member)

(Reference)
Brief Personal History of the candidates for new members of the Board of Directors and the Audit & Supervisory Board

1. Brief Personal History of the candidate for new member of the Board of Directors

(1) Minoru Usui (Mr.)

Birthdate: April 22, 1955

Nov. 1979	Joined Shinshu Seiki Co., Ltd. (currently Seiko Epson Corporation)
June 2002	Director, Seiko Epson Corporation
Nov. 2005	General Administrative Manager, Production Engineering & Development Division, Seiko Epson Corporation
July 2007	General Administrative Manager, Corporate Research & Development Division, Seiko Epson Corporation
Oct. 2007	Managing Director, Seiko Epson Corporation
June 2008	President and Representative Director, Seiko Epson Corporation Chief Executive Officer, Seiko Epson Corporation
April 2020	Chairman and Director, Seiko Epson Corporation (up to the present)

2. Brief Personal History of the candidate for new member of the Audit & Supervisory Board

(1) Mayumi Mochizuki (Ms.)

Birthdate: March 10, 1954

April 1976	Joined Nippon Roche K.K. (currently Chugai Pharmaceutical Co., Ltd.)
April 1983	Department of Pharmacy, Kitasato University Hospital
April 1997	Associate Professor, Graduate School of Pharmaceutical Sciences, Chiba University
Sept. 2000	Professor, School of Pharmacy, Kitasato University
April 2007	Professor, Kyoritsu University of Pharmacy
April 2008	Professor, Faculty of Pharmacy, Keio University
April 2009	Associate Dean in Pharmacy, Graduate School of Pharmaceutical Sciences, Keio University
July 2013	Dean, Faculty of Pharmacy; Dean, Graduate School of Pharmaceutical Sciences, Keio University
Oct. 2015	Director, Department of Pharmacy, Keio University Hospital
April 2019	Professor Emeritus, Keio University (up to the present)
April 2019	Project Professor, Faculty of Pharmacy, Keio University
April 2019	Adviser, International Medical Information Center (up to the present)
April 2020	Special Adviser, International University of Health and Welfare (up to the present)
Oct. 2020	Vice President, Science Council of Japan (up to the present)